Abbott says agreement reached to reopen baby formula plant
Abbott did not immediately detail the terms of the agreement reached with the Food and Drug Administration, which has been investigating safety problems at the Sturgis, Michigan, facility. The consent decree is a binding legal agreement between the company and the federal government.
Share:
More Stories
1:31
Tips for businesses to thrive with rising rent
yesterday1:48
The Cost Of: Holiday lights
2ds ago
Fortnite players 'tricked' into unwanted purchases are starting to get refunds. Here's how to apply
2ds ago2:08
Brooklyn senior loses $120,000 in crypto art scam as DA sounds alarm on growing crypto fraud
6ds ago0:31
Anthem Blue Cross Blue Shield reverses decision to put a time limit on anesthesia
7ds ago1:13
Friday was last day for roadway outdoor dining; practice resumes April 1
13ds ago1:31
Tips for businesses to thrive with rising rent
yesterday1:48
The Cost Of: Holiday lights
2ds agoFortnite players 'tricked' into unwanted purchases are starting to get refunds. Here's how to apply
2ds ago2:08
Brooklyn senior loses $120,000 in crypto art scam as DA sounds alarm on growing crypto fraud
6ds ago0:31
Anthem Blue Cross Blue Shield reverses decision to put a time limit on anesthesia
7ds ago1:13
Friday was last day for roadway outdoor dining; practice resumes April 1
13ds ago
WASHINGTON - Infant formula maker Abbott says it's reached an agreement with U.S. health officials to restart production at its largest domestic factory, a key step toward easing a nationwide shortage tied to the plant’s shutdown earlier this year.
Abbott did not immediately detail the terms of the agreement reached with the Food and Drug Administration, which has been investigating safety problems at the Sturgis, Michigan, facility. The consent decree is a binding legal agreement between the company and the federal government.
After production resumes, Abbott has said it will take at least eight weeks to begin shipping new product to stores.
The Biden administration has come under intense pressure over the last week to do more to ease the shortage of formula that has forced parents of infants to go to significant lengths to feed their children.
Abbott’s plant came under scrutiny earlier this year after four infants became sick with bacterial infections after consuming powdered formula from the Michigan factory. Two of the babies died.
In February, the company halted production and recalled several brands of formula. Those steps squeezed supplies that were already strained by supply chain disruptions and parents stockpiling during COVID-19.
More from News 12
0:31
Mayor Adams announces Citi Bike service expansion
1:48
BITTER BLAST: Sunny with frigid temps today for the Bronx
1:22
Bitter cold weather continues in the Bronx
1:28
Real Deal: Coffee, eggs, heat prices all rising in New York
1:37
Drone sightings reported over LaGuardia Airport
1:28
